Results

Total Results: 344 records

Showing results for "lung cancer".
Users also searched for: lung cancer screening

101. Archived: Oral Cancer: Screening, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/oral-cancer-screening-1996
     January 01, 1996 - minimal, older male smokers who took beta-carotene for 5-8 years experienced slightly higher rates of lung … cancer and overall mortality in a recently completed trial in Finland. 22   Return to Table of Contents … The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

102. U.S. Preventive Services Task Force Highlights High-Priority Evidence Gaps in 2021 Report to Congress (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/2021-annual-report-congress-bulletin.pdf
     January 01, 2021 - for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors • Screening for Lung … Cancer • Screening for Colorectal Cancer The research gaps in this report highlight various issues

103. Screening for Ovarian Cancer - Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/za7BqXMwT8BMz4Z_ygrvKm
     May 01, 2004 - Screening for Ovarian Cancer - Recommendation Statement Summary of Recommendation The U.S. Preventive Services Task Force (USPSTF) recommends against routine screening for ovarian cancer. D recommendation. The USPSTF found fair evidence that screening with serum CA-125 level or transvaginal ultrasound can detect ov…

104. Screening for Oral Cancer - Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/smwZyuqbG_e_XcpRHx8JWd
     November 01, 2004 - limit alcohol use in order to decrease their risk for oral cancer as well as heart disease, stroke, lung … cancer, and cirrhosis.

105. 8Gdsduvu-Wpf5Zafh93592 (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/8GDsDuVu-WpF5zafh93592
     December 01, 2013 - Neither vitamin E nor �-carotene prevented CVD or cancer, and �-carotene increased lung cancer risk in … We found a probable increase in lung cancer incidence in high-risk subgroups (smokers and as- bestos … and death for individuals at high risk for lung cancer (24, 29, 72). … Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. … Selenium and lung cancer: a systematic review and meta analysis. PLoS One. 2011;6:e26259.

106. Medicines to Help Prevent Breast Cancer: Let's Talk About It (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/breast-cancer-risk-reduction-discussion-guide_3.pdf
     September 01, 2019 - Medicines to Help Prevent Breast Cancer: Let's Talk About It Medicines to Help Prevent Breast Cancer Let’s Talk About It We all want to find better ways to help prevent breast cancer. Medicines that reduce the risk of breast cancer are one way to help some women lower their risk. Women who have a hig…

107. Medicines to Help Prevent Breast Cancer: Let's Talk About It (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/breast-cancer-risk-reduction-discussion-guide.pdf
     September 01, 2019 - Medicines to Help Prevent Breast Cancer: Let's Talk About It Medicines to Help Prevent Breast Cancer Let’s Talk About It We all want to find better ways to help prevent breast cancer. Medicines that reduce the risk of breast cancer are one way to help some women lower their risk. Women who have a hig…

108. Evidence Summary: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/menopausal-hormone-therapy-preventive-medication
     December 12, 2017 - Outcomes with no statistically significant reductions in risk included colorectal cancer, lung cancer … No statistically significant differences for cervical cancer, endometrial cancer, lung cancer, ovarian … cancer, coronary heart disease, quality of life, and all-cause mortality. … Lung cancer among postmenopausal women treated with estrogen alone in the Women's Health Initiative randomized … Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a

109. Archived: Evidence Summary: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/menopausal-hormone-therapy-preventive-medication-december-2017
     December 12, 2017 - Outcomes with no statistically significant reductions in risk included colorectal cancer, lung cancer … No statistically significant differences for cervical cancer, endometrial cancer, lung cancer, ovarian … cancer, coronary heart disease, quality of life, and all-cause mortality. … Lung cancer among postmenopausal women treated with estrogen alone in the Women's Health Initiative randomized … Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a

110. Screening for Ovarian Cancer: A Brief Evidence Update (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/k2QHcwuK4NkvxFXhvGrbwY
     May 01, 2004 - Screening for Ovarian Cancer: A Brief Evidence Update Background In 1996, the USPSTF stated that routine screening for ovarian cancer by ultrasound, the measurement of serum tumor markers, or pelvic examination was not recommended (D recommendation).1 There was insufficient evidence to recommend for or against the …

111. Archived: Addendum to Screening for Ovarian Cancer: Evidence Update for the U.S. Preventive Services Task Force Reaffirmation Recommendation Statement: Ovarian Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/addendum-to-screening-for-ovarian-cancer-evidence-update-for-the-us-preventive-services-task-force-reaffirmation-recommendation-statement/ovarian-cancer-screening-2012
     April 15, 2012 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Addendum to Screening for Ovarian Cancer: Evidence Update for the U.S. Preventive Services Task Force Reaffirmation Recommendation Statement Ovarian Cancer: Screening Ap…

112. Recommendation: Ovarian Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/ovarian-cancer-screening
     February 13, 2018 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Recommendation Statement Ovarian Cancer: Screening February 13, 2018 Recommendations made by the USPSTF are independent of the U.S. government. They should not be cons…

113. Archived: Final Evidence Review: Ovarian Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review78/ovarian-cancer-screening-2012
     April 15, 2012 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Evidence Review Ovarian Cancer: Screening April 15, 2012 Recommendations made by the USPSTF are independent of the U.S. government. They should not be constr…

114. Archived: Ovarian Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/ovarian-cancer-screening-2012
     September 15, 2012 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Recommendation Statement Ovarian Cancer: Screening September 15, 2012 Recommendations made by the USPSTF are independent of the U.S. government. They should …

115. Eighth Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/usptf-annual-report-congress-2018%20(1).pdf
     January 01, 2018 - For example, in 2004, the USPSTF issued an I statement on screening for lung cancer. … • Of the four studies that the Task Force considered on the benefits of screening for lung cancer, … Reduced lung-cancer mortality with low-dose computed tomographic screening. … B Lung Cancer: Screening in Adults Ages 55 to 80 Years The USPSTF recommends annual screening for … lung cancer with low-dose computed tomography in adults ages 55 to 80 years who have a 30 pack-year

116. U.S. Preventive Services Task Force Issues Draft Recommendation Statement: Medications for Risk Reduction of Primary Breast Cancer in Women (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/bcpmbulletin.pdf
     April 16, 2013 - U.S. Preventive Services Task Force Issues Draft Recommendation Statement: Medications for Risk Reduction of Primary Breast Cancer in Women U.S. Preventive Services Task Force Issues Draft Recommendation Statement: Medications for Risk Reduction of Primary Breast Cancer in Women WASHINGTON, D.C. – April 16, 2013…

117. U.S. Preventive Services Task Force Issues Final Recommendation Statement on Medications for Risk Reduction of Primary Breast Cancer in Women (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/breastcanmedsbulletin.pdf
     September 24, 2013 - U.S. Preventive Services Task Force Issues Final Recommendation Statement on Medications for Risk Reduction of Primary Breast Cancer in Women U.S. Preventive Services Task Force Issues Final Recommendation Statement on Medications for Risk Reduction of Primary Breast Cancer in Women WASHINGTON, D.C. – Sept. 24, …

118. Addendum to Screening for Ovarian Cancer: Evidence Update for the USPSTF Reaffirmation Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/QtuWfedsMmUb_sAuKWdsGg
     December 31, 2014 - Addendum to Screening for Ovarian Cancer: Evidence Update for the USPSTF Reaffirmation Recommendation Statement Addendum to Screening for Ovarian Cancer: Evidence Update for the U.S. Preventive Services Task Force Reaffirmation Recommendation Statement Prepared for: Agency for Healthcare Research and Qu…

119. Evidence Summary: Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary28/menopausal-hormone-therapy-preventive-medication
     November 01, 2022 - cancer, coronary heart disease, peripheral arterial disease, probable dementia, quality of life, and … Estrogen plus progestin and lung cancer: follow-up of the Women’s Health Initiative randomized trial. … Clin Lung Cancer . 2016;17(1):10-7.e1. doi:10.1016/j.cllc.2015.09.004 30. … Lung cancer among postmenopausal women treated with estrogen alone in the Women's Health Initiative randomized … Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a

120. Archived: Final Evidence Review: Ovarian Cancer: Screening, May 2004 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review79/ovarian-cancer-screening-2004
     May 15, 2004 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Evidence Review Ovarian Cancer: Screening, May 2004 May 15, 2004 Recommendations made by the USPSTF are independent of the U.S. government. They should no…